[ Price : $8.95]
HHS directs FDA and other health agency employees to immediately stop using the artificial intelligence platform Claude after the ...[ Price : $8.95]
FDA approves a Synergy Spine Solutions PMA for its Synergy Disc, a motion-preserving artificial cervical disc.[ Price : $8.95]
A leading myeloma researcher says FDAs draft guidance endorsing minimal residual disease as a potential basis for accelerated drug...[ Price : $8.95]
Drug user fee negotiators confront lingering divisions over FDAs America First proposals and the structure of hiring commitments, ...[ Price : $8.95]
The U.S. Department of Justice (DoJ) says a Federal Circuit ruling on so-called generic drug skinny labels threatens to undermine ...[ Price : $8.95]
Rare disease drug developers and patient advocates are applauding a series of new guidance documents from FDA that bring long-awai...[ Price : $8.95]
The U.S. Senate Special Committee on Aging raises concerns about FDAs handling of foreign drug manufacturing violations and how th...[ Price : $8.95]
FDA accepts for priority review an Ionis Pharmaceuticals supplemental NDA for olezarsen for treating severe hypertriglyceridemia.